Angiotensin II receptor blockers could prevent the development of atherosclerosis beyond reducing blood pressure in monkeys fed a high-cholesterol diet. However, it has been unclear whether hypotensive effects improve atherosclerosis in primates. We investigated whether antihypertensive agents, an angiotensin II receptor antagonist, candesartan, and a calcium channel blocker, amlodipine, prevent areas of atherosclerotic lesions in the aorta of monkeys fed a high-cholesterol diet. Seventeen male monkeys fed a high-cholesterol diet for 6 months were grouped as follows: a high-cholesterol diet group (n 5), a candesartan-treated group Angiotensin II has been shown to be a potent vasoconstrictor, and it also promotes vascular proliferation via induction of several growth factors and cytokines (4, 5). We previously reported that ACE activity in atherosclerotic lesions in monkeys fed a high-cholesterol diet was increased significantly compared with that in normal lesions (6,7). In this atherosclerotic model, an ACE inhibitor or an angiotensin II receptor blocker (ARB) significantly reduced the progression of atherosclerosis beyond reduction of blood pressure and plasma cholesterol levels (6-8). The mechanism of angiotensin II in the development of atherosclerosis is thought to be various angiotensin II-induced actions such as the induction of growth factors, inflammatory cytokines, adhesion